http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 01 Jul 2026 16:21:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+YOUNG+WILLIAM+D/26721026.html si-local-file:///var/storage/secattach/20260701/26721026.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+YOUNG+WILLIAM+D/26721026.html Wed, 01 Jul 2026 16:21:00 -0400 AUTL O.37399203 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+YOUNG+WILLIAM+D/26721026.html si-local-file:///var/storage/secattach/20260701/26721026.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+YOUNG+WILLIAM+D/26721026.html Wed, 01 Jul 2026 16:21:00 -0400 AUTL O.37399203 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Rao+Madduri+Ravin/26720974.html si-local-file:///var/storage/secattach/20260701/26720974.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Rao+Madduri+Ravin/26720974.html Wed, 01 Jul 2026 16:19:00 -0400 AUTL O.37399203 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Rao+Madduri+Ravin/26720974.html si-local-file:///var/storage/secattach/20260701/26720974.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Rao+Madduri+Ravin/26720974.html Wed, 01 Jul 2026 16:19:00 -0400 AUTL O.37399203 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Richardson+Ryan/26720923.html si-local-file:///var/storage/secattach/20260701/26720923.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Richardson+Ryan/26720923.html Wed, 01 Jul 2026 16:17:00 -0400 AUTL O.37399203 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Richardson+Ryan/26720923.html si-local-file:///var/storage/secattach/20260701/26720923.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Richardson+Ryan/26720923.html Wed, 01 Jul 2026 16:17:00 -0400 AUTL O.37399203 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Leiderman+Elisabeth/26720869.html si-local-file:///var/storage/secattach/20260701/26720869.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Leiderman+Elisabeth/26720869.html Wed, 01 Jul 2026 16:15:00 -0400 AUTL O.37399203 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Leiderman+Elisabeth/26720869.html si-local-file:///var/storage/secattach/20260701/26720869.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Leiderman+Elisabeth/26720869.html Wed, 01 Jul 2026 16:15:00 -0400 AUTL O.37399203 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Iannone+Robert/26720773.html si-local-file:///var/storage/secattach/20260701/26720773.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Iannone+Robert/26720773.html Wed, 01 Jul 2026 16:13:00 -0400 AUTL O.37399203 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Iannone+Robert/26720773.html si-local-file:///var/storage/secattach/20260701/26720773.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Iannone+Robert/26720773.html Wed, 01 Jul 2026 16:13:00 -0400 AUTL O.37399203 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+BUTITTA+CYNTHIA+M/26720749.html si-local-file:///var/storage/secattach/20260701/26720749.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+BUTITTA+CYNTHIA+M/26720749.html Wed, 01 Jul 2026 16:11:00 -0400 AUTL O.37399203 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+BUTITTA+CYNTHIA+M/26720749.html si-local-file:///var/storage/secattach/20260701/26720749.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+BUTITTA+CYNTHIA+M/26720749.html Wed, 01 Jul 2026 16:11:00 -0400 AUTL O.37399203 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Bain+Linda/26720684.html si-local-file:///var/storage/secattach/20260701/26720684.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Bain+Linda/26720684.html Wed, 01 Jul 2026 16:09:00 -0400 AUTL O.37399203 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Bain+Linda/26720684.html si-local-file:///var/storage/secattach/20260701/26720684.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Bain+Linda/26720684.html Wed, 01 Jul 2026 16:09:00 -0400 AUTL O.37399203 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Azelby+Robert/26720652.html si-local-file:///var/storage/secattach/20260701/26720652.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Azelby+Robert/26720652.html Wed, 01 Jul 2026 16:07:00 -0400 AUTL O.37399203 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Azelby+Robert/26720652.html si-local-file:///var/storage/secattach/20260701/26720652.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+Azelby+Robert/26720652.html Wed, 01 Jul 2026 16:07:00 -0400 AUTL O.37399203 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+BONNEY+MICHAEL+W/26720582.html si-local-file:///var/storage/secattach/20260701/26720582.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+BONNEY+MICHAEL+W/26720582.html Wed, 01 Jul 2026 16:05:00 -0400 AUTL O.37399203 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+BONNEY+MICHAEL+W/26720582.html si-local-file:///var/storage/secattach/20260701/26720582.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Autolus+Therapeutics++++++For%3A+Jun+29++Filed+by%3A+BONNEY+MICHAEL+W/26720582.html Wed, 01 Jul 2026 16:05:00 -0400 AUTL O.37399203 http://www.streetinsider.com/Press+Releases/Autolus+Therapeutics+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26720544.html <p align="justify">LONDON &amp; GAITHERSBURG, Md., July 01, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies and candidates, today announced that the Compensation Committee of the Company's Board of Directors granted stock option awards to purchase an aggregate of 25,420 American Depositary Shares and 87,530 restricted stock units (RSUs), each representing an equal number of ordinary shares, to 13 employees pursuant to the Company’s 2025 Inducement Plan. The stock options and RSUs were granted as an inducement material to the individual becoming an employee of Autolus http://www.streetinsider.com/Press+Releases/Autolus+Therapeutics+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26720544.html Wed, 01 Jul 2026 16:05:00 -0400 AUTL AUTL http://www.streetinsider.com/Press+Releases/Autolus+Therapeutics+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26720544.html <p align="justify">LONDON &amp; GAITHERSBURG, Md., July 01, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies and candidates, today announced that the Compensation Committee of the Company's Board of Directors granted stock option awards to purchase an aggregate of 25,420 American Depositary Shares and 87,530 restricted stock units (RSUs), each representing an equal number of ordinary shares, to 13 employees pursuant to the Company’s 2025 Inducement Plan. The stock options and RSUs were granted as an inducement material to the individual becoming an employee of Autolus http://www.streetinsider.com/Press+Releases/Autolus+Therapeutics+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26720544.html Wed, 01 Jul 2026 16:05:00 -0400 AUTL AUTL http://www.streetinsider.com/Globe+Newswire/Autolus+Therapeutics+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26720544.html <p align="justify">LONDON &amp; GAITHERSBURG, Md., July 01, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies and candidates, today announced that the Compensation Committee of the Company's Board of Directors granted stock option awards to purchase an aggregate of 25,420 American Depositary Shares and 87,530 restricted stock units (RSUs), each representing an equal number of ordinary shares, to 13 employees pursuant to the Company’s 2025 Inducement Plan. The stock options and RSUs were granted as an inducement material to the individual becoming an employee of Autolus http://www.streetinsider.com/Globe+Newswire/Autolus+Therapeutics+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26720544.html Wed, 01 Jul 2026 16:05:00 -0400 AUTL AUTL http://www.streetinsider.com/Globe+Newswire/Autolus+Therapeutics+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26720544.html <p align="justify">LONDON &amp; GAITHERSBURG, Md., July 01, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies and candidates, today announced that the Compensation Committee of the Company's Board of Directors granted stock option awards to purchase an aggregate of 25,420 American Depositary Shares and 87,530 restricted stock units (RSUs), each representing an equal number of ordinary shares, to 13 employees pursuant to the Company’s 2025 Inducement Plan. The stock options and RSUs were granted as an inducement material to the individual becoming an employee of Autolus http://www.streetinsider.com/Globe+Newswire/Autolus+Therapeutics+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26720544.html Wed, 01 Jul 2026 16:05:00 -0400 AUTL AUTL http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Autolus+Therapeutics++++++For%3A+Jun+29/26706330.html si-local-file:///var/storage/secattach/20260629/26706330.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Autolus+Therapeutics++++++For%3A+Jun+29/26706330.html Mon, 29 Jun 2026 16:03:00 -0400 AUTL O.37399203 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Autolus+Therapeutics++++++For%3A+Jun+29/26706330.html si-local-file:///var/storage/secattach/20260629/26706330.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Autolus+Therapeutics++++++For%3A+Jun+29/26706330.html Mon, 29 Jun 2026 16:03:00 -0400 AUTL O.37399203 http://www.streetinsider.com/Press+Releases/Autolus+Therapeutics+to+Participate+in+Upcoming+Investor+Conference/26687953.html <p align="justify">LONDON and GAITHERSBURG, Md., June 25, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announced that the Company will participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference.</p> <p align="justify">Autolus Chief Executive Officer Dr. Christian Itin will present in a Fireside Chat on Tuesday, June 30, 2026 at 9:00am EDT / 14:00pm BST.</p> <p align="justify">A webcast of the fireside chat will be available on the “Events” page in the “Investor Relations &amp; Media” section of the Company’s website at https://www.autolus.com/investor-relations-media/events/. http://www.streetinsider.com/Press+Releases/Autolus+Therapeutics+to+Participate+in+Upcoming+Investor+Conference/26687953.html Thu, 25 Jun 2026 07:00:00 -0400 AUTL AUTL